A big earnings hit from United Technologies (NYSE: UTX ) has helped the markets climb higher today, and the Dow Jones Industrial Average (DJINDICES: ^DJI ) has gained more than 40 points as of 2:20 p.m. EDT. UTC's not the only blue-chip stock to have reported quarterly results today, but it's the best member of the Dow today, leading a group of modest risers on the index. Let's go around the Dow to catch up on the earnings action you need to know about.
UTC hits the mark
Industrial conglomerate United Technologies' acquisition of aerospace parts maker Goodrich last year helped the company's sales climb 16% year over year for the most recent quarter -- part of a strong report that has propelled the stock higher by 3.3% so far today. Earnings per share grew by more than 27% to $1.70, smashing average analyst projections of $1.58.
The success was enough to push UTC to raise its expectations for 2013: The firm announced that full-year EPS could climb between 12% and 15%. High demand in the aerospace sector has made the company's acquisition of Goodrich a well-timed buy, and UTC's CEO is confident that the economy's ongoing recovery will only strengthen that momentum. It's not just the U.S. providing growth, however: Sales from the company's Otis elevator unit in China grew by 39% for the quarter.
Hot Small Cap Stocks To Invest In 2015: RigNet Inc.(RNET)
RigNet, Inc. provides remote communications services for the oil and gas industry. It offers remote communications services through a controlled and managed Internet protocol/multiprotocol label switching (IP/MPLS) global network, enabling drilling contractors, oil companies, and oilfield service companies to communicate. The company offers a communications package of voice, data, video, networking, and real-time data management to offshore and land-based remote locations. It primarily provides voice-over-Internet-protocol, data, and high-speed Internet access, as well as other value-added services, such as video conferencing solutions, TurboNet solutions for wide area network, real-time data management solutions, Wi-Fi hotspots and Internet kiosks, wireless intercoms, and handheld radios. The company also offers Secure Oil Information Link, a managed members-only communications network hub that enables collaborative partners, suppliers, and customers to transfer and share data. It serves the owners and operators of offshore drilling rigs and production facilities, land rigs, remote offices, and supply bases primarily in the United States, Brazil, Norway, the United Kingdom, Nigeria, Qatar, Saudi Arabia, Singapore, and Australia. The company was founded in 2000 and is headquartered in Houston, Texas.
Advisors' Opinion:- [By Seth Jayson]
Calling all cash flows
When you are trying to buy the market's best stocks, it's worth checking up on your companies' free cash flow once a quarter or so, to see whether it bears any relationship to the net income in the headlines. That's what we do with this series. Today, we're checking in on RigNet (Nasdaq: RNET ) , whose recent revenue and earnings are plotted below.
Top 5 Tech Stocks To Own For 2014: Furiex Pharmaceuticals Inc (FURX)
Furiex Pharmaceuticals, Inc. is a drug development collaboration company. The Company�� product pipeline includes two marketed products and three programs in development, including late-stage compounds, in multiple therapeutic areas. Its programs include Priligy, Alogliptin Nesina, Alogliptin/Actose Combination, Alogliptin/Metformin Combination, Fluoroquinolone, Mu Delta and PPD 10558. In November 2011, it acquired full exclusive license rights to develop and commercialize the compound MuDelta under its existing development and license agreement with Janssen Pharmaceutica N.V.
Priligy (dapoxetine) is a drug developed for the on-demand treatment of premature ejaculation (PE). Dapoxetine is a short-acting, selective serotonin reuptake inhibitor (SSRI) designed to be taken only when needed one to three hours before sexual intercourse is anticipated rather than every day. Nesina (alogliptin) is a drug for the oral treatment of type 2 diabetes (T2D). Alogliptin is a DPP-4 inhibitor that slows the inactivation of incretin hormones glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic peptide (GIP).
Fluoroquinolone drug candidate is a Phase II-ready novel fluoroquinolone antibiotic that is being developed by the Company for the treatment of complicated skin and skin structure infections, such as abscesses that occur deep in the skin layers and respiratory infections. This antibiotic has a spectrum of activity and is able to treat methicillin-resistant staphylococcus aureus (MRSA) infections. The Company is developing both oral and intravenous (IV) formulations. The Company is developing Mu Delta for treatment of diarrheal predominant irritable bowel syndrome (d-IBS). The Company is conducting a Phase II study on an oral formulation of Mu Delta.
The Company is developing PPD 10558 for the treatment of dyslipidemia. PPD 10558 has shown muscle safety in preclinical studies by minimizing the delivery of the drug to the muscle. The Company has filed an inve! stigational new drug (IND) application with the United States Food and Drug Association and completed five clinical studies.
Advisors' Opinion:- [By Jake L'Ecuyer]
Top Headline
Forest Laboratories (NYSE: FRX) announced its plans to buy Furiex Pharmaceuticals (NASDAQ: FURX) for up to $1.46 billion. Forest will pay around $95 per share, or around $1.1 billion in cash. Forest Labs will also pay up to $30 per share, or around $360 million in a contingent value right. The deal is projected to close in the second or third quarter of 2014. - [By John Udovich]
Yesterday, small cap drug development collaboration company Furiex Pharmaceuticals Inc (NASDAQ: FURX) surged 129.91% after announcing that its experimental drug had alleviated diarrhea and abdominal pain caused by irritable bowel syndrome in two studies, meaning its worth taking a closer look at the stock because that�� a condition that effects millions of people (with no other effective drug to treat it) plus take a look at the�performance of biotech benchmarks iShares NASDAQ Biotechnology Index ETF (NASDAQ: IBB) and SPDR S&P Biotech ETF (NYSEARCA: XBI).
- [By Lisa Levin]
Furiex Pharmaceuticals (NASDAQ: FURX) shares moved up 28.41% to $102.92. The volume of Furiex Pharmaceuticals shares traded was 2285% higher than normal. Forest Labs (NYSE: FRX) announced its plans to buy Furiex Pharma for up to $1.46 billion.
Top 5 Tech Stocks To Own For 2014: Lam Research Corporation(LRCX)
Lam Research Corporation designs, manufactures, markets, refurbishes, and services semiconductor processing equipments used in the fabrication of integrated circuits. The company offers etch products that remove portions of various films from the wafer in the creation of semiconductor devices. Its etch products include dielectric etch, conductor etch, three-dimensional integrated circuit etch, MEMS devices, CMOS image sensors, and power devices for etching process. Lam Research Corporation also provides wafer cleaning steps that comprise post-etch and post-strip cleans, and pre-diffusion and pre-deposition cleans; and single-wafer wet clean and plasma-based bevel clean systems. The company offers its products to semiconductor manufacturers. It operates in the United States, Europe, Taiwan, Korea, Japan, and the Asia Pacific. Lam Research Corporation was founded in 1980 and is headquartered in Fremont, California.
Advisors' Opinion:- [By Brian Stoffel]
3. Lam Research (NASDAQ: LRCX ) , P/E of 166
Lam's core business is in making equipment that helps to manufacture computer chips. The company trades at a lofty 166 times earnings right now, but if Lam is able to meet analyst expectations for 2013, today's price is just 12 times expected earnings. - [By Markus Aarnio]
Lam Research Corporation (LRCX) designs, manufactures, markets, refurbishes, and services semiconductor processing equipment used in the fabrication of integrated circuits.
- [By Stephen Simpson, CFA]
Ultratech isn't the only game in town, though, and there are multiple technologies and process steps that are going to play significant roles in the production of FinFETs and 3D circuits. With that, I would take a look at Mattson Technologies (MTSN), as this company has already accomplished the not-so-easy task of gaining meaningful share in the dry strip, rapid thermal processing (RTP), and etch markets despite competing with giants like Lam Research (LRCX), Applied Materials (AMAT), and Tokyo Electron (TOELY.PK).
Top 5 Tech Stocks To Own For 2014: Tableau Software Inc (DATA)
Tableau Software, Inc., incorporated on July 19, 2004, is a computer software company. The Company�� products are used by people across all kinds of organizations, including Fortune 500 corporations, small and medium-sized businesses, government agencies, universities, research institutions and non-profits. Organizations employ its products in a range of use cases, such as increasing sales, streamlining operations, improving customer service, managing investments, assessing quality and safety, studying and treating diseases, completing academic research, addressing environmental problems and improving education. The Company�� product helps a single user on a laptop analyze data from a simple spreadsheet, or to enable thousands of users across an enterprise to execute queries against databases.
The Company�� technology includes VizQL and its Hybrid Data Architecture. VizQL, translates drag-and-drop actions into data queries and then expresses that information visually. VizQL unifies the formerly disparate tasks of query and visualization and allows users to transform questions into pictures without the need for software scripts, chart wizards or dialogue boxes that inhibit speed and flexibility. The Company�� Hybrid Data Architecture combines the power and flexibility of its Live Query and In-Memory Data Engines. The Company�� Live Query Engine allows users to instantaneously connect to volumes of data in its existing format and location, reducing the need for time-consuming data transformation processes that only technical specialists can perform. In addition, this capability allows customers to leverage investments in their existing data platforms and to capitalize on the capabilities of high performance databases. The Company�� In-Memory Data Engine enables users to import amounts of data into its own in-memory database.
Advisors' Opinion:- [By GURUFOCUS]
Tableau Software, Inc. (DATA), a recent IPO, was a strong contributor to performance during the second quarter. Tableau offers proprietary data discovery and visualization tools that help business users analyze and derive insights from business data. Unlike traditional business intelligence platforms, Tableau is intuitive to use, fast to deploy, and can be configured without involving the IT department.We estimate that Tableau serves a market that is in excess of $20 billion annually, or more than 100 times larger than the company's current revenue base, leaving a long runway for growth. (Neal Rosenberg)
- [By Telis Demos and Douglas MacMillan Opower Inc., which helps electric utilities push homeowners to use]
A steady stream of so-called “big data” companies like Opower have gone public lately, including software firms Splunk Inc.(SPLK) and Tableau Software Inc.(DATA) Those stocks have each more than doubled since their debuts in 2012 and earlier this year, respectively.
No comments:
Post a Comment